Follow The Filings

VOR Vor Biopharma

Vor Biopharma earnings company data as of 4:48 AM ET 10/23

Limited consensus data for this ticker (thin coverage or data-plan limits). Dates may be company-announced rather than sell-side consensus. Calendar and recent prints remain the primary lens when available.

Scheduled

1 period, newest first, nothing reported yet. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q3 12 Nov EPS — — —
Rev — — —

Insider trades

Open-market buys and sales by VOR's executives, directors and 10% owners in the last 12 months, from their Form 4s

All VOR insider trades
  • None no insider bought on the open market
  • $66M sold by 1 insider outside a trading plan
  • None no planned (10b5-1) sales
  1. Ra Capital Management, L.P. 10% owner, +3 joint filers
    Sale
    $4,207 213 shares at $19.75 <0.1% of stake
    Traded Jul 16 Filed Jul 21
  2. Ra Capital Management, L.P. Director, +3 joint filers
    Sale
    $2.6M 165,150 shares at $15.77 6.4% of stake
    Traded Apr 22 Filed Apr 24
  3. Ra Capital Management, L.P. Director, +3 joint filers
    Sale
    $10.2M 630,374 shares at $16.14 20% of stake
    Traded Apr 17–20 Filed Apr 21
  4. Ra Capital Management, L.P. Director, +3 joint filers
    Sale
    $11.9M 737,989 shares at $16.10 19% of stake
    Traded Apr 13–15 Filed Apr 15
  5. Ra Capital Management, L.P. Director, +3 joint filers
    Sale
    $10.2M 620,133 shares at $16.50 14% of stake
    Traded Apr 8–10 Filed Apr 10
  6. Ra Capital Management, L.P. Director, +3 joint filers
    Sale
    $14.5M 849,257 shares at $17.10 16% of stake
    Traded Apr 2–6 Filed Apr 6
  7. Ra Capital Management, L.P. Director, +3 joint filers
    Sale
    $10.4M 400,408 shares at $25.90 34% of stake
    Traded Oct 28–30 Filed Oct 30, 2025
  8. Ra Capital Management, L.P. Director, +3 joint filers
    Sale
    $6.2M 221,166 shares at $28.06 16% of stake
    Traded Oct 23–27 Filed Oct 27, 2025
  9. Ra Capital Management, L.P. Director, +4 joint filers
    Sale
    $3.4M 117,050 shares at $29.34 7.7% of stake
    Traded Oct 20–21 Filed Oct 22, 2025
  10. Reprogrammed Interchange LLC 10% owner, +1 joint filer
    Sale
    $1.1M 37,533 shares at $30.19 3.1% of stake
    Traded Oct 17–21 Filed Oct 21, 2025
  11. Reprogrammed Interchange LLC 10% owner, +1 joint filer
    Sale
    $2.3M 73,676 shares at $31.88 5.8% of stake
    Traded Oct 15–16 Filed Oct 17, 2025
  12. Ra Capital Management, L.P. Director, +4 joint filers
    Sale
    $13.7M 464,025 shares at $29.54 97% of stake
    Traded Oct 15–17 Filed Oct 17, 2025
  13. Reprogrammed Interchange LLC 10% owner, +1 joint filer
    Sale
    $3M 96,657 shares at $31.08 7% of stake
    Traded Oct 10–14 Filed Oct 15, 2025
  14. Reprogrammed Interchange LLC 10% owner, +1 joint filer
    Sale
    $4.1M 124,146 shares at $33.16 8.3% of stake
    Traded Oct 8–9 Filed Oct 10, 2025

Also filed in the last 12 months, not counted as buying or selling: 3 option exercises, 1 stock grant, and 1 sale back to the company.

SEC filings

Recent issuer filings from EDGAR, 23 shown.

Filed Form Detail Links
SCHEDULE 13G/A —
SCHEDULE 13G/A —
SCHEDULE 13G/A —
10-Q
SCHEDULE 13G/A —
SCHEDULE 13G —
SCHEDULE 13G —
SCHEDULE 13D/A —
8-K 5.02,9.01
8-K 5.07,9.01
8-K 7.01,9.01
SCHEDULE 13G/A —
SCHEDULE 13G/A —
10-Q
SCHEDULE 13G/A —
SCHEDULE 13G/A —
DEF 14A
DEFA14A
SCHEDULE 13D/A —
SCHEDULE 13D/A —
SCHEDULE 13D/A —
SCHEDULE 13D/A —
SCHEDULE 13G —

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.